Pages
Pension Automatic Re-Enrolment July 2022
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/pension-automatic-re-enrolment-july-2022
DCHS reservist’s role in Coronation celebrations
https://dchs.nhs.uk/news/dchs-reservists-role-coronation-celebrations
Dr Chris Clayton appointed as Chief Executive Designate JUCD
The appointment of Dr Chris Clayton as Chief Executive Designate of the NHS Integrated Care Board for Derby and Derbyshire.
Files
DCHS WDES Data Report 2022.pdf
DCHS WDES Data Report 2022
Risk Stratification Decision Protocol for Patients with Impaired Mobility and a Wound Regarding Treatment Location (S101)
This Protocol aims to ensure patients with wounds receive treatment in the appropriate setting (outpatient clinic or patient’s home). The primary aims of this Protocol are to: 1) ensure patient safety, 2) reduce the risk of injury to staff, 3) increase equity in service access for patients, 4) facilitate clinician decision making, 5) facilitate communication between teams, 6) reduce the risk of claims of discrimination, and 7) reduce staff time lost through inappropriate referrals.
Employee Online Bank Workers Guide v1.6.pdf
Bank Worker Employee Online Guide
WBC Information Sheet JUCD
WBC Information Sheet JUCD
0204 - ISHS Virology Service Prescription for Outpatient Supply from CRHFT
0204 - ISHS Virology Service Prescription for Outpatient Supply from CRHFT
A1a - Administration guide for SPOA (P91)
A1a - Administration guide for SPOA
Select Task Template
Select Task Template
HRP37 Managing Allegations Against Staff PiPoT Policy - Appendix 4 - A Just Culture Guide
HRP37 Managing Allegations Against Staff PiPoT Policy - Appendix 4 - A Just Culture Guide
NMP Prescribing Supervision Template (A4 P57)
NMP Prescribing Supervision Template
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010